Table 2.
Most common used fractionations and Clinical Target Volume for non-malignant pathologies.
| Benign disorder | Fractionation | Total dose | CTV* |
|---|---|---|---|
| Acute/chronic inflammatory disorders | |||
| Hidradenitis suppurativa | 0.2−1 Gy 5fx*/week until response | 0.6−5 Gy | Gland affection |
| Sialorrhea | 4 Gy 2-3fx/week | 10-20 Gy | Submandibular gland and 2/3 parotids |
| Acute/chronic painful degenerative diseases | |||
| Insertion tendinitis | 0.5−1 Gy 2-3fx/week |
5−12 Gy | Tendon insertion |
| Synovitis | Synovial Bag | ||
| Osteoarthritic disease | Osteoarthritic affected articulation | ||
| Hypertrophic disorders of soft tissues | |||
| Dupuytren/ Ledderhose/ Peyronie | 2−4 Gy 5fx/week | 20-40 Gy | Regional involvement with margin |
| Keloids | 2−5 Gy 1–2 fx/week | 12−21 Gy | Surgical bed +0.5 cm |
| Pterygium | 10 Gy 1fx/week | 30-60 Gy | Conjunctive injury |
| Gynecomastia | 2−5 Gy 5fx/week | 20-30 Gy | Breast |
| Functional diseases | |||
| Dysthytoid ophthalmopathy | 1.5−2 Gy 5fx/week | 10-20 Gy | Retrobulbar orbital volume |
| Orbital pseudotumor | 2 Gy 5fx/week | 20 Gy | |
| Arteriovenous malformations | 16−25 Gy Single fraction | 16−25 Gy | Vascular alteration with margin |
| Age-related macular degeneration | 1.8 Gy 4fx/week | 14.4 Gy | Posterior chamber |
| Lymphatic fistula | 0.5−1 Gy 4-5fx/week | 3−10 Gy | Fistulous path |
| Dermatologic diseases | |||
| Eczemas | 0.5−1 Gy 1–2fx/week | 4−5 Gy | Affected area with margins |
| Psoriasic nail bed lesions | 1−2 Gy 1–2/week | 6−8 Gy | Nail bed |
| Heterotrophic ossification | 7 Gy Single fraction | 7 Gy | Articulation and peri-articular soft tissues |
| Calcaneal spur | 0.5 Gy 2fx/week | 5 Gy | Calcaneus and achilles tenson insertion |
| Vertebral hemangioma | 2 Gy 5fx/week | 30-40 Gy | Spinal body affected |
*
CTV: Clinical Target Volume; fx: fractions.